Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825872 | Current Opinion in Pharmacology | 2016 | 7 Pages |
Abstract
Bipolar disorder has a bidirectional interaction with immune dysfunction, and immune dysfunction may mediate the bidirectional relationship between bipolar disorder and inflammatory disorders. Increased inflammation is present in a subset of patients with bipolar disorder, including those with comorbid bipolar disorder and inflammatory disease. Anti-inflammatory agents may have a role in treating bipolar disorder by acting at multiple targets to inhibit these interactions, particularly in those with inflammatory comorbidities.131
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Joshua D Rosenblat, Jonathan M Gregory, Roger S McIntyre,